2016 - 2017 Academic Year
MCB/ECH 294 Schedule

2017 Spring Schedule

All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated

April 7, 2017
LSA 1022

Organizational Meeting
Dr. Judy Kjelstrom - Co-Instructor, Biotechnology Program & DEB Program Coordinator
Prof. Karen McDonald - Co-Instructor, ECH
Co-Prof. Ray Rodriguez - Co-Instructor, MCB

April 14, 2017
LSA 1022

The Antibody Discovery Paradigm
Aaron K Sato, PhD, Chief Scientific Officer LakePharma, Belmont, CA

April 21, 2017
LSA 1022

Advanced Microbial Selection (AMS): a unique discovery strategy for microbes that improve plant health and productivity
Susan Turner, PhD, Senior Vice President, Research & Discovery
BioConsortia Inc.,
Davis

April 28, 2017
LSA 1022

TBA
Todd Meyerrose, PhD
Vice President,
P4G Capital, San Francisco

May 5, 2017
LSA 1022

From Galaxy Evolution to the Genomics Revolution: Perspectives of a Self-taught Bioinformatician
Jason Harris, PhD

Director, Bioinformatics Engineering, Personalis Inc.
,San Francisco, CA

May 12, 2017
LSA 1022

Why entrepreneurship makes sense
Benjamin R. Wang, MD, Founder and Chief Medical Officer
, NeVap Inc., Emeryville

May 19, 2017
LSA 1022

TBA
Donna M. Dambach, VMD, PhD, Diplomate, ACVP, Senior Director, Head of Toxicology, Safety Assessment, Genentech, Inc., San Francisco, CA

May 26, 2017LSA 1022

Putting the D in Biopharmaceutical Research & Development
Matthew Schenauer, PhD

Senior Research Scientist, Gilead Sciences,
Oceanside

June 2, 2017
LSA 1022


 

 

Bio-Based Fuels & Chemicals: Technology Development Development and Commercialization at JBEI (Joint BioEnergy Institute)
Peter Matlock, PhD, Director, Technology Commercialization JBEI: Joint BioEnergy Institute, JBEI: Joint BioEnergy Institute, Emeryville

 


 

 


   

Reports are due by 5 pm on Friday, June 15, 2017